Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

20 pages, Feb 2019

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Weaker growth due to seasonal factors

Cough, cold and allergy (hay fever) remedies was only partially able to benefit from the more positive economic sentiment in the Netherlands, recording weaker growth in 2017 and 2018 than other large OTC categories. The growth rates for these two years also remained noticeably behind the more vigorous sales increase witnessed in 2016.

The shorter flu season hampers growth in 2018

To a significant extent, annual sales of cough, cold and allergy (hay fever) remedies remain reliant on the impact of seasonal factors. There are two important seasons during which demand spikes.

Antihistamines/allergy remedies buoyed by the rising incidence of hay fever

The second crucial season for cough, cold and allergy (hay fever) remedies is the spring, when allergies surge, especially hay fever. Unsurprisingly, antihistamines/allergy remedies emerged in recent years as the most dynamic category.

COMPETITIVE LANDSCAPE

Modern grocery retailers gains ground at the expense of chemists/pharmacies

As in most other important OTC categories, sales of cough, cold and allergy (hay fever) remedies are increasingly shifting from chemists/pharmacies to supermarkets and other modern grocery retailers. Drugstores/parapharmacies remains the preferred sales channel by a large distance.

Lofthouse of Fleetwood and GSK Consumer Healthcare continue to lead

Lofthouse of Fleetwood and GSK Consumer Healthcare remained the leading players in cough, cold and allergy (hay fever) remedies in the Netherlands in 2018. The leading position of Lofthouse of Fleetwood reflects the fact that medicated confectionery accounts for the biggest share of value sales in cough, cold and allergy (hay fever) remedies.

New product development remains strong

New product development remained relatively strong in cough, cold and allergy (hay fever) remedies in 2017 and 2018 compared with other established OTC categories. Consequently, several new products showed strong growth.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Netherlands with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Netherlands, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Netherlands market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Netherlands?
What are the major brands in Netherlands?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands - Category analysis

HEADLINES

PROSPECTS

Weaker growth due to seasonal factors

The shorter flu season hampers growth in 2018

Antihistamines/allergy remedies buoyed by the rising incidence of hay fever

COMPETITIVE LANDSCAPE

Modern grocery retailers gains ground at the expense of chemists/pharmacies

Lofthouse of Fleetwood and GSK Consumer Healthcare continue to lead

New product development remains strong

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 3 Sales of Decongestants by Category: Value 2013-2018
Table 4 Sales of Decongestants by Category: % Value Growth 2013-2018
Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Consumer Health in the Netherlands - Industry Overview

EXECUTIVE SUMMARY

Moderate value growth, largely driven by non-OTC categories

OTC sales are not (yet) lifted by the brighter macroeconomy

Pharmaceutical multinationals dominate, with private label the main rival

Supermarkets gains ground, to the detriment of chemists/pharmacies

Modest value growth over the forecast period

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

Summary 1 OTC: Switches

MARKET INDICATORS

Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 10 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 11 Sales of Consumer Health by Category: Value 2013-2018
Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format: % Value 2013-2018
Table 17 Distribution of Consumer Health by Format and Category: % Value 2018
Table 18 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Weaker growth due to seasonal factors

The shorter flu season hampers growth in 2018

Antihistamines/allergy remedies buoyed by the rising incidence of hay fever

COMPETITIVE LANDSCAPE

Modern grocery retailers gains ground at the expense of chemists/pharmacies

Lofthouse of Fleetwood and GSK Consumer Healthcare continue to lead

New product development remains strong

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands - Category analysis

HEADLINES

PROSPECTS

Weaker growth due to seasonal factors

The shorter flu season hampers growth in 2018

Antihistamines/allergy remedies buoyed by the rising incidence of hay fever

COMPETITIVE LANDSCAPE

Modern grocery retailers gains ground at the expense of chemists/pharmacies

Lofthouse of Fleetwood and GSK Consumer Healthcare continue to lead

New product development remains strong

CATEGORY DATA

Consumer Health in the Netherlands - Industry Overview

EXECUTIVE SUMMARY

Moderate value growth, largely driven by non-OTC categories

OTC sales are not (yet) lifted by the brighter macroeconomy

Pharmaceutical multinationals dominate, with private label the main rival

Supermarkets gains ground, to the detriment of chemists/pharmacies

Modest value growth over the forecast period

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

MARKET INDICATORS

MARKET DATA

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports